Mala Ramanathan, P. Sankara Sarma, Udaya S. Mishra | Indian Journal of Medical Ethics | Vol 9, No 4 (2012) Introduction India’s regulatory framework for research ethics is two pronged. Schedule Y of the Drugs and Cosmetics Act, 1940, of the… Continue reading
Gagandeep Kang | Indian Journal of Medical Ethics | Vol iX No 2 | April – June 2012 With the recent highlighting of ethical issues in several clinical trials, and the increase in awareness among parliamentarians, there has been some… Continue reading
Gagandeep Kang | Indian Journal of Medical Ethics | Vol 9, No. | 2012 Abstract With the recent highlighting of ethical issues in several clinical trials, and the increase in awareness among parliamentarians, there has been some concern about the… Continue reading
S. Srinivasan | Economic and Political Weekly | Vol 47, Issue 25 | 23 June 2012 The Central Drugs Standard Control Organisation is expected to protect the citizen from the marketing of harmful pharmaceuticals. The fi ndings of the 59th… Continue reading
Amy Yee | The Lancet | Vol 379, No 9814 | 2012 Ethical violations in clinical trials in India have exposed gaping holes in the country’s regulatory system, which has struggled to oversee the booming industry. Amy Yee reports from… Continue reading
Elizabeth R. Pike | 7 September 2011 | American Journal of Law & Medicine | Vol. 38 | 2012 Abstract National advisory committees have considered the obligations owed to research participants in the event of research-related injuries. These committees have… Continue reading
